Financials Lonza Group AG

Equities

LONN

CH0013841017

Biotechnology & Medical Research

Market Closed - Swiss Exchange 11:30:46 2024-06-19 EDT 5-day change 1st Jan Change
473.4 CHF -0.75% Intraday chart for Lonza Group AG -2.41% +33.84%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 26,224 42,255 56,574 33,615 26,273 34,140 - -
Enterprise Value (EV) 1 29,185 45,068 55,616 33,429 27,195 36,856 37,459 37,390
P/E ratio 40.8 x 48.9 x 19.3 x 27.7 x 39.8 x 38.3 x 30.6 x 25.1 x
Yield 0.78% 0.53% 0.39% 0.66% 1.13% 0.96% 1.13% 1.29%
Capitalization / Revenue 4.43 x 6.83 x 10.5 x 5.4 x 3.91 x 5.13 x 4.48 x 4.01 x
EV / Revenue 4.93 x 7.29 x 10.3 x 5.37 x 4.05 x 5.53 x 4.91 x 4.39 x
EV / EBITDA 18 x 26.1 x 33.4 x 16.8 x 13.6 x 20.2 x 17.3 x 14.8 x
EV / FCF 146 x 287 x -449 x -39.2 x -91.6 x -226 x 462 x 111 x
FCF Yield 0.69% 0.35% -0.22% -2.55% -1.09% -0.44% 0.22% 0.9%
Price to Book 4.03 x 6.2 x 5.82 x 3.18 x 2.76 x 3.53 x 3.34 x 3.08 x
Nbr of stocks (in thousands) 74,246 74,289 74,283 74,189 74,282 72,117 - -
Reference price 2 353.2 568.8 761.6 453.1 353.7 473.4 473.4 473.4
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,920 6,185 5,409 6,223 6,717 6,661 7,623 8,524
EBITDA 1 1,624 1,728 1,665 1,995 1,999 1,826 2,167 2,526
EBIT 1 1,249 1,358 1,151 1,397 939 1,169 1,482 1,800
Operating Margin 21.1% 21.96% 21.28% 22.45% 13.98% 17.56% 19.45% 21.12%
Earnings before Tax (EBT) 1 849 986 760 1,448 790 1,091 1,371 1,691
Net income 1 645 869 2,944 1,215 654 892.8 1,107 1,353
Net margin 10.9% 14.05% 54.43% 19.52% 9.74% 13.4% 14.52% 15.87%
EPS 2 8.650 11.63 39.52 16.34 8.880 12.37 15.48 18.83
Free Cash Flow 1 200 157 -124 -852 -297 -163.3 81.03 338.1
FCF margin 3.38% 2.54% -2.29% -13.69% -4.42% -2.45% 1.06% 3.97%
FCF Conversion (EBITDA) 12.32% 9.09% - - - - 3.74% 13.39%
FCF Conversion (Net income) 31.01% 18.07% - - - - 7.32% 24.99%
Dividend per Share 2 2.750 3.000 3.000 3.000 4.000 4.552 5.328 6.106
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 2,944 3,074 3,111 2,542 2,867 2,982 3,241 3,078 3,639 3,032 3,643
EBITDA 1 796 893 835 847 818 987 1,008 922 1,077 801.1 1,038
EBIT 1 606 706 652 606 545 698 699 563 376 502.9 700.4
Operating Margin 20.58% 22.97% 20.96% 23.84% 19.01% 23.41% 21.57% 18.29% 10.33% 16.59% 19.23%
Earnings before Tax (EBT) 1 407 564 422 296 464 594 854 486 304 442.4 646.4
Net income 1 346 477 392 319 2,625 492 723 410 244 366.2 532.2
Net margin 11.75% 15.52% 12.6% 12.55% 91.56% 16.5% 22.31% 13.32% 6.71% 12.08% 14.61%
EPS 2 4.640 6.390 5.240 4.280 35.24 6.610 9.730 5.540 3.340 4.990 7.270
Dividend per Share 2 - - 3.000 3.000 - - 3.000 3.500 - 4.000 -
Announcement Date 1/21/20 7/24/20 1/27/21 7/23/21 1/26/22 7/22/22 1/25/23 7/21/23 1/26/24 - -
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,961 2,813 - - 922 2,716 3,319 3,250
Net Cash position 1 - - 958 186 - - - -
Leverage (Debt/EBITDA) 1.823 x 1.628 x - - 0.4612 x 1.487 x 1.532 x 1.287 x
Free Cash Flow 1 200 157 -124 -852 -297 -163 81 338
ROE (net income / shareholders' equity) 10.1% 13.1% 35.5% 11.9% 6.52% 9.08% 11% 12.7%
ROA (Net income/ Total Assets) 4.65% 6.15% 19.1% 7.19% 3.82% 5.22% 6.25% 7.34%
Assets 1 13,884 14,135 15,444 16,907 17,103 17,104 17,714 18,445
Book Value Per Share 2 87.60 91.70 131.0 143.0 128.0 134.0 142.0 154.0
Cash Flow per Share 2 13.20 15.10 16.30 13.70 18.80 22.20 24.30 29.50
Capex 1 786 973 1,300 1,872 1,682 1,593 1,597 1,597
Capex / Sales 13.28% 15.73% 24.03% 30.08% 25.04% 23.91% 20.94% 18.73%
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
473.4 CHF
Average target price
583.7 CHF
Spread / Average Target
+23.31%
Consensus
  1. Stock Market
  2. Equities
  3. LONN Stock
  4. Financials Lonza Group AG